Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-09-17

Clinical Trial Update: Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma [Phase 1]

View source ↗

Summary

A phase 1 clinical trial evaluating bleomycin with or without electroporation therapy in patients with stage III or IV melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bleomycin (bleomycin)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Melanoma (Skin) | Phase 1 | Status: UNKNOWN